Nurse Practitioner · Heavener, OK
NPI
1033132964
Since 2006
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
704 Hwy 270
Heavener, OK, 74937
Phone (918) 653-3723
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
436 services
Medicare patients, 2024
125
Average age 71
Drug cost, 2024
$1.2M
3,975 prescriptions
Company payments, 2025
$50.06
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Patricia J Redhage was code 99215 (office e&m - established), 230 times for 108 patients. In total Patricia J Redhage billed 436 services in 5 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-10-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 230 | 108 | $82.47 | $19K |
| 95251 Test - Miscellaneous | Facility | 104 | 57 | $21.16 | $2,201 |
| 99214 Office E&M - Established | Facility | 99 | 65 | $58.13 | $5,755 |
By year: 2022 $22K for 292 services; 2023 $28K for 445 services; 2024 $27K for 436 services.
Medicare prescription drug claims, 2024
In 2024, the drug Patricia J Redhage prescribed most often to Medicare patients was Jardiance (Empagliflozin), with 452 prescriptions and refills. In total Patricia J Redhage wrote 3,975 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Jardiance Empagliflozin | 452 | 452 | 65 | $283K |
| Ozempic Semaglutide | 441 | 447 | 54 | $434K |
| Metformin Hcl Er Metformin Hcl | 431 | 431 | 58 | $6,625 |
| Alcohol Swabs Alcohol Antiseptic Pads | 238 | 246 | 50 | $1,525 |
| Novolog Flexpen Insulin Aspart | 234 | 316 | 47 | $46K |
| Atorvastatin Calcium Generic | 175 | 175 | 26 | $4,004 |
| Lisinopril Generic | 166 | 166 | 20 | $490 |
| Toujeo Max Solostar Insulin Glargine,hum.Rec.Anlog | 150 | 163 | 21 | $173K |
| Tresiba Flextouch U-100 Insulin Degludec | 108 | 130 | 29 | $74K |
| Insulin Glargine-Yfgn Generic | 100 | 134 | 27 | $12K |
| Synthroid Levothyroxine Sodium | 96 | 96 | 13 | $4,071 |
| Pioglitazone Hcl Generic | 94 | 94 | 15 | $1,726 |
| Metformin Hcl Generic | 70 | 70 | Under 11 | $1,197 |
| Gabapentin Generic | 56 | 56 | Under 11 | $744 |
| Fenofibrate Generic | 55 | 55 | Under 11 | $1,189 |
Brand drugs: 1,928 claims; generic drugs: 1,725 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Patricia J Redhage $50.06 ($50.06 in general payments such as food, travel and fees) from 1 company. The largest payer was Tandem Diabetes Care, Inc. with $50.06.
| Company | Payments | Amount |
|---|---|---|
| Tandem Diabetes Care, Inc. TNDM | 2 | $50.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.